GlassScriptPhysician profile
Daniel S Difrischia
NPI 1942256078
$201.16
in general payments reported to CMS, 2019-2025
9 companies · $30.05 in 2025
The $30.05 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.39 · 2020: $73.35 · 2021: $12.37 · 2025: $30.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $30.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $30.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $44.79 | 2020-2021 | |
| Enterra Medical, INC. | $30.05 | 2025 | |
| Merck Sharp & Dohme LLC | $25.65 | 2019 | |
| Lundbeck LLC | $22.40 | 2020 | |
| Portola Pharmaceuticals, LLC | $18.53 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $17.78 | 2019 | |
| Pfizer INC. | $15.73 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.28 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.95 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Difrischia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.